Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,305,549
-
Share change
-
-84,909
-
Total reported value
-
$7,234,000
-
Price per share
-
$2.19
-
Number of holders
-
23
-
Value change
-
-$346,474
-
Number of buys
-
11
-
Number of sells
-
11
Institutional Holders of ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) as of Q4 2021
As of 31 Dec 2021,
ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,305,549 shares.
The largest 10 holders included
TPG GP A, LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA ADVISERS, LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, DIMENSIONAL FUND ADVISORS LP, and Janney Montgomery Scott LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.